The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD.
Medrxiv : The Preprint Server For Health Sciences
Amanat, Fatima F; Thapa, Mahima M; Lei, Tinting T; Sayed Ahmed, Shaza M SM; Adelsberg, Daniel C DC; Carreno, Juan Manuel JM; Strohmeier, Shirin S; Schmitz, Aaron J AJ; Zafar, Sarah S; Zhou, Julian Q JQ; Rijnink, Willemijn W; Alshammary, Hala H; Borcherding, Nicholas N; Reiche, Ana Gonzalez AG; Srivastava, Komal K; Sordillo, Emilia Mia EM; van Bakel, Harm H; , ; Turner, Jackson S JS; Bajic, Goran G; Simon, Viviana V; Ellebedy, Ali H AH; Krammer, Florian F